This little company could be producing one of the most revolutionizing medical products in decades. And for investors, this is the perfect time to get in on the ground floor. Taglich Brothers is estimating revenue could rise to $18 million by 2017 up from a projected $2 million for 2013. Military is also interested, which will boost sales of this oxygen generating product. Really excited about this stock!
There won't be any price increase unless the company can demonstrate that it can see the units. ...Just because they have signed up distributors does not mean much unless there is 'sell thru'. The balance sheet is in horrible shape and sales could resolve a lot of those balance sheet issues.